{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T07:22:57Z","timestamp":1781594577018,"version":"3.54.5"},"reference-count":74,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2007,9,19]],"date-time":"2007-09-19T00:00:00Z","timestamp":1190160000000},"content-version":"vor","delay-in-days":18,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wound Repair Regeneration"],"published-print":{"date-parts":[[2007,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Inflammation and wound healing are inextricably linked and complex processes, and are deranged in the setting of chronic, nonhealing diabetic foot ulcers (DFU). An ideal therapy for DFU should both suppress excessive inflammation while enhancing healing. We reasoned that biological simulation would clarify mechanisms and help refine therapeutic approaches to DFU. We developed an agent\u2010based model (ABM) capable of reproducing qualitatively much of the literature data on skin wound healing, including changes in relevant cell populations (macrophages, neutrophils, fibroblasts) and their key effector cytokines (tumor necrosis factor\u2010\u03b1 [TNF], interleukin [IL]\u20101\u03b2, IL\u201010, and transforming growth factor [TGF]\u2010\u03b21). In this simulation, a normal healing response results in tissue damage that first increases (due to wound\u2010induced inflammation) and then decreases as the collagen levels increase. Studies by others suggest that diabetes and DFU are characterized by elevated TNF and reduced TGF\u2010\u03b21, although which of these changes is a cause and which one is an effect is unclear. Accordingly, we simulated the genesis of DFU in two ways, either by (1) increasing the rate of TNF production fourfold or (2) by decreasing the rate of TGF\u2010\u03b21 production 67% based on prior literature. Both manipulations resulted in increased inflammation (elevated neutrophils, TNF, and tissue damage) and delayed healing (reduced TGF\u2010\u03b21 and collagen). Our ABM reproduced the therapeutic effect of platelet\u2010derived growth factor\/platelet releasate treatment as well as DFU debridement. We next simulated the expected effect of administering (1) a neutralizing anti\u2010TNF antibody, (2) an agent that would increase the activation of endogenous latent TGF\u2010\u03b21, or (3) latent TGF\u2010\u03b21 (which has a longer half\u2010life than active TGF\u2010\u03b21), and found that these therapies would have similar effects regardless of the initial assumption of the derangement that underlies DFU (elevated TNF vs. reduced TGF\u2010\u03b21). <jats:italic>In silico<\/jats:italic> methods may elucidate mechanisms of and suggest therapies for aberrant skin healing.<\/jats:p>","DOI":"10.1111\/j.1524-475x.2007.00271.x","type":"journal-article","created":{"date-parts":[[2007,9,22]],"date-time":"2007-09-22T00:17:49Z","timestamp":1190420269000},"page":"671-682","source":"Crossref","is-referenced-by-count":140,"title":["Agent\u2010based model of inflammation and wound healing: insights into diabetic foot ulcer pathology and the role of transforming growth factor\u2010\u03b21"],"prefix":"10.1111","volume":"15","author":[{"given":"Qi","family":"Mi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Rivi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Clermont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Steed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoram","family":"Vodovotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,9,19]]},"reference":[{"key":"e_1_2_7_2_2","first-page":"205","article-title":"Inflammation. 1","volume":"11","author":"Hart J.","year":"2002","journal-title":"its role in the healing of acute wounds"},{"key":"e_1_2_7_3_2","first-page":"245","article-title":"Inflammation. 2","volume":"11","author":"Hart J.","year":"2002","journal-title":"its role in the healing of chronic wounds"},{"key":"e_1_2_7_4_2","first-page":"345","article-title":"Growth factors bFGF and TGF beta accelerate the rate of wound repair in normal and in diabetic rats","volume":"10","author":"Broadley KN","year":"1988","journal-title":"Int J Tissue React"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4804(91)90196-S"},{"key":"e_1_2_7_6_2","first-page":"1","article-title":"The effect of tumor necrosis factor\u2010alpha on wound healing. An experimental study","volume":"211","author":"Rapala K.","year":"1996","journal-title":"Ann Chir Gynaecol"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.1041300213"},{"key":"e_1_2_7_8_2","first-page":"1","article-title":"IL\u20106 signal transduction and its physiological roles","volume":"149","author":"Kamimura D","year":"2003","journal-title":"the signal orchestration model"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.00-0073com"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004140050163"},{"key":"e_1_2_7_11_2","first-page":"275","volume-title":"The molecular and cellular biology of wound repair","author":"Roberts AB","year":"1996"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.00229"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature01320"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ccx.0000139360.30327.69"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.shk.0000168526.97716.f3"},{"key":"e_1_2_7_16_2","first-page":"7","article-title":"Diabetic foot ulcers","volume":"7","author":"Boulton AJ","year":"1999","journal-title":"a framework for prevention and care"},{"issue":"1","key":"e_1_2_7_17_2","first-page":"6S","article-title":"The diabetic neuropathic ulcer","volume":"45","author":"Browne AC","year":"1999","journal-title":"an overview"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0094-1298(20)30624-6"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.21.4.518"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.22.3.382"},{"key":"e_1_2_7_21_2","first-page":"191","article-title":"Diabetic foot ulcers","volume":"1993","author":"Levin ME.","journal-title":"pathogenesis and management"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9136(199611)13:11<967::AID-DIA266>3.0.CO;2-K"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00400414"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-5491.2002.00692.x"},{"key":"e_1_2_7_25_2","first-page":"61","article-title":"Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group","volume":"183","author":"Steed DL","year":"1996","journal-title":"J Am Coll Surg"},{"key":"e_1_2_7_26_2","first-page":"1235","article-title":"PDGF and FGF stimulate wound healing in the genetically diabetic mouse","volume":"136","author":"Greenhalgh DG","year":"1990","journal-title":"Am J Pathol"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0094-1298(20)32471-8"},{"key":"e_1_2_7_28_2","first-page":"557","article-title":"Theoretical models of wound healing","volume":"325","author":"Sherratt JA","year":"2002","journal-title":"past successes and future challenges"},{"key":"e_1_2_7_29_2","first-page":"535","article-title":"Genetic susceptibility to keloid disease and hypertrophic scarring","volume":"111","author":"Bayat A","year":"2003","journal-title":"transforming growth factor beta1 common polymorphisms and plasma levels"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6109(02)00208-6"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0370-1573(88)90003-8"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-08539-4"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1098\/rspb.1990.0061"},{"key":"e_1_2_7_34_2","first-page":"135","article-title":"Continuum model of fibroblast\u2010driven wound contraction","volume":"158","author":"Tranquillo RT","year":"1992","journal-title":"inflammation-mediation"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1006\/jsre.1993.1135"},{"key":"e_1_2_7_36_2","unstructured":"CookJ.A mathematical model for dermal wound healing: wound contraction and scar formation. Thesis Seattle: University of Washington 1995."},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1006\/jtbi.1995.0230"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1524-475X.2001.00278.x"},{"key":"e_1_2_7_39_2","first-page":"153","article-title":"Agent\u2010based computational modeling of epithelial cell monolayers","volume":"3","author":"Walker DC","year":"2004","journal-title":"predicting the effect of exogenous calcium concentration on the rate of wound closure"},{"key":"e_1_2_7_40_2","first-page":"89","article-title":"The epitheliome","volume":"76","author":"Walker DC","year":"2004","journal-title":"agent-based modelling of the social behaviour of cells"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000139707.13729.7D"},{"key":"e_1_2_7_42_2","first-page":"255","article-title":"Wounds","volume":"9","author":"Cockbill S.","year":"2002","journal-title":"the healing process"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6109(05)70566-1"},{"key":"e_1_2_7_44_2","first-page":"217","volume-title":"Novel cytokine inhibitors","author":"Letterio JJ","year":"2000"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.18.1.64"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1999.79.4.1283"},{"key":"e_1_2_7_47_2","first-page":"35","article-title":"Integrating the results of Phase IV (postmarketing) clinical trial with four previous trials reinforces the position that Regranex (becaplemin) gel 0.01% is an effective adjunct to the treatment of diabetic foot ulcers","volume":"5","author":"Robson MC","year":"2005","journal-title":"J Appl Res"},{"key":"e_1_2_7_48_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.15.11.1598"},{"key":"e_1_2_7_49_2","first-page":"198","article-title":"A randomized, controlled multicenter, dose response trial of activated platelet supernatant, topical CT102 in chronic, non\u2010healing, diabetic wounds","volume":"5","author":"Holloway G","year":"1993","journal-title":"Wounds"},{"key":"e_1_2_7_50_2","first-page":"961","article-title":"Platelet releasate treatment improves skin healing in diabetic rats through endogenous growth factor secretion","volume":"44","author":"Moulin V","year":"1998","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"e_1_2_7_51_2","doi-asserted-by":"publisher","DOI":"10.1006\/jtbi.1993.1007"},{"key":"e_1_2_7_52_2","doi-asserted-by":"publisher","DOI":"10.1007\/0-306-48382-3_110"},{"key":"e_1_2_7_53_2","first-page":"2061","article-title":"In silico design of clinical trials","volume":"32","author":"Clermont G","year":"2004","journal-title":"a method coming of age"},{"key":"e_1_2_7_54_2","first-page":"S15","article-title":"Growth factors","volume":"8","author":"Carter K.","year":"2003","journal-title":"the wound healing therapy of the future"},{"key":"e_1_2_7_55_2","first-page":"72","article-title":"Wound healing","volume":"38","author":"Robson MC","year":"2001","journal-title":"biologic features and approaches to maximize healing trajectories"},{"key":"e_1_2_7_56_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.4019"},{"key":"e_1_2_7_57_2","first-page":"2142","article-title":"Regulation of transforming growth factor\u2010\u03b21 by nitric oxide","volume":"59","author":"Vodovotz Y","year":"1999","journal-title":"Cancer Res"},{"key":"e_1_2_7_58_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.6.3000-3009.2003"},{"key":"e_1_2_7_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1089-8603(02)00002-2"},{"key":"e_1_2_7_60_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1524-475X.1994.20406.x"},{"key":"e_1_2_7_61_2","first-page":"508","article-title":"Use of homologous platelet factors in achieving total healing of recalcitrant skin ulcers","volume":"108","author":"Atri SC","year":"1990","journal-title":"Surgery"},{"key":"e_1_2_7_62_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-198609000-00011"},{"key":"e_1_2_7_63_2","first-page":"133","article-title":"Effects of transforming growth factors \u03b22 on wound healing in diabetic foot ulcers","volume":"2","author":"Robson MC","year":"2002","journal-title":"J Appl Res"},{"key":"e_1_2_7_64_2","first-page":"93","article-title":"Granulocyte\u2010macrophage colony\u2010stimulating factor in foot ulcers","volume":"6","author":"Agrawal RP","year":"2003","journal-title":"Diabetic Foot"},{"key":"e_1_2_7_65_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.4.1094-1098.2001"},{"key":"e_1_2_7_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)04495-4"},{"key":"e_1_2_7_67_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.6.1856"},{"key":"e_1_2_7_68_2","first-page":"513","article-title":"Diabetes\u2010impaired healing and reduced wound nitric oxide synthesis","volume":"121","author":"Schaffer MR","year":"1997","journal-title":"a possible pathophysiologic correlation"},{"key":"e_1_2_7_69_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1998.00268.x"},{"key":"e_1_2_7_70_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI2067"},{"key":"e_1_2_7_71_2","doi-asserted-by":"publisher","DOI":"10.1006\/jtbi.2000.2012"},{"key":"e_1_2_7_72_2","first-page":"283","article-title":"Wound healing","volume":"9","author":"Diegelmann RF","year":"2004","journal-title":"an overview of acute, fibrotic and delayed healing"},{"key":"e_1_2_7_73_2","unstructured":"Food and Drug Administration.Innovation or stagnation: challenge and opportunity on the critical path to new medical products. 1\u201338. 2004."},{"key":"e_1_2_7_74_2","first-page":"14090","article-title":"Latent transforming growth factor\u2010\u03b2 in serum","volume":"262","author":"O'Connor\u2010McCourt MD","year":"1987","journal-title":"a specific complex with \u03b12-macroglobulin"},{"key":"e_1_2_7_75_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.174.6.1549"}],"container-title":["Wound Repair and Regeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1524-475X.2007.00271.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1524-475X.2007.00271.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T01:27:01Z","timestamp":1697246821000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1524-475X.2007.00271.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":74,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["10.1111\/j.1524-475X.2007.00271.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1524-475x.2007.00271.x","archive":["Portico"],"relation":{},"ISSN":["1067-1927","1524-475X"],"issn-type":[{"value":"1067-1927","type":"print"},{"value":"1524-475X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}